Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Studies validating performance of Pall prion reduction technology presented at AABB

Studies validating performance of Pall prion reduction technology presented at AABB

October 18, 2005

Research studies demonstrating the effectiveness of prion filtration technology to safeguard the blood supply are being presented at the AABB Annual Meeting in Seattle, Washington today. Prion diseases, such as variant Creutzfeldt-Jakob Disease (vCJD), the human form of Bovine Spongiform Encephalopathy or "mad cow" disease, are of growing concern to blood services worldwide because of the potential for transmission through transfusion from asymptomatic donors. Pall Corporation (NYSE: PLL) is presenting research results further validating the performance of its Leukotrap® Affinity Prion Reduction Filter System, which was CE marked with a 99.9 percent prion removal efficiency in May 2005. It is the first technology that reduces infectious prions from red cells, the most widely transfused blood component.

A new study conducted by the American Red Cross and the Eastern Virginia Medical School, Norfolk Va., et.al., found that red blood cells filtered through the Leukotrap Affinity Prion Reduction Filter System retain their therapeutic value and quality after 42 days of storage. The samples tested showed mean values of 85.0 and 82.9 percent in vivo red cell recovery, exceeding the FDA required mean of 75 percent for stored red cells. Post-storage hemolysis (breakdown of red cell membrane) values were well below the FDA maximum limit. The researchers concluded that both in vivo and in vitro results of this study indicate that leukoreduced red cell products filtered through the Pall system demonstrated acceptable quality for transfusion.




Sam Coker, Ph.D., Principal Scientist of Pall Corporation, presented results of research testing the filter against sporadic CJD, the most common form of prion disease that affects humans. The study, conducted with the Departments of Neurology, Psychiatry and Pathology of the New York University School of Medicine, showed a 99.9 percent reduction of the prion.

"This study, a first with a true human form of prion disease, provides additional confirmation of the performance of our technology to remove all types of prions that can adversely affect people," said Dr. Coker. The sporadic CJD study is one of a series of studies underscoring the filter's capability in reducing all types of prions from blood, including scrapie (a prion disease affecting sheep) and mouse-adapted human vCJD.

Dr. Coker also presented the results of research on the performance characteristics of the Pall Leukotrap Affinity Prion Reduction Filter under a range of different blood processing conditions, which may vary by country and blood center. The results showed that the new filter was effective in removing infectious scrapie prions from different preparations of red cell concentrates at different temperatures. In addition to prion removal, the study also measured the level of leukocyte reduction (resulting in removal of about 5 logs) and the quality of red cells before and after filtration, showing that normal cell qualities were maintained.

Pall developed the Pall Leukotrap Prion Affinity Reduction Filter System to help blood authorities around the world stop the transmission of prions as part of the Company's mission to help safeguard the global blood supply. Its prion technology is currently under evaluation by the Irish Blood Transfusion Service and the English National Blood Service for integration into their respective practices as a blood safety measure to reduce the risk of vCJD prion transmission. Pall is continuing its prion research and development program to apply its technologies to meet the specific requirements of each nation throughout Europe, the epicenter of vCJD, followed by North America and Asia.

Pall Corporation



Related Prions Current Events and Prions News Articles Prions Current Events and Prions News RSS Prions Current Events and Prions News RSS
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.

Cell study explains why younger people more at risk of vCJD
Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe.

Prion study reveals first direct information about the protein's molecular structure
A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions.

One nano-step closer to weighing a single atom
By studying gold nanoparticles with highly uniform sizes and shapes, scientists now understand how they lose energy, a key step towards producing nanoscale detectors for weighing any single atom.

Scripps Florida scientists devise accelerated method to determine infectious prion strainsScripps Florida scientists devise accelerated method to determine infectious prion strains
Current tests to identify specific strains of infectious prions, which cause a range of transmissible diseases (such as mad cow) in animals and humans, can take anywhere from six months to a year to yield results - a time-lag that may put human populations at risk.

Redefining what it means to be a prion
Whitehead Institute researchers have quintupled the number of identifiable prion proteins in yeast and have further clarified the role prions play in the inheritance of both beneficial and detrimental traits.

Prion discovery gives clue to control of mass gene expression
The discovery in common brewer's yeast of a new, infectious, misfolded protein -- or prion -- by University of Illinois at Chicago molecular biologists raises new questions about the roles played by these curious molecules, often associated with degenerative brain diseases like "mad cow" and its human counterpart, Creutzfeldt-Jakob.

Antibody key to treating variant CJD, scientists find
Scientists at the University of Liverpool have determined the atomic structure of the 'binding' between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.

Self-regulating molecular 'transformers' control intracellular protein delivery
Scientists from the California Institute of Technology (Caltech) have uncovered the Transformer like properties of molecules responsible for carrying and depositing proteins to their correct locations within cells.

Study confirms vCJD could be transmitted by blood transfusion
The findings underline the importance of precautions against vCJD transmission, such as the Government decision in 2004 to ban blood donations from anyone who had received a blood transfusion since 1980.
More Prions Current Events and Prions News Articles
The Pathological Protein: Mad Cow, Chronic Wasting, and Other Deadly Prion Diseases

The Pathological Protein: Mad Cow, Chronic Wasting, and Other Deadly Prion Diseases
by Philip Yam (Author)

In 1996, British doctors were horrified to discover that mad cow disease (BSE), an affliction that had been plaguing British cattle for ten years, had jumped the species barrier and was appearing in humans as variant Creutzfeldt-Jakob disease (vCJD). Not unlike the mad cows, victims of vCJD suffer from a degenerative neurological disease that peppers the brain with microscopic holes, causing dementia, loss of motor control, and certain death. What alarms researchers and public health officials worldwide is that the incubation period for vCJD may be as long as 10 or even 15 years, and during this period those infected are symptom-free. And because the disease is so far undetectable except by autopsy, there is no way of knowing with certainty how many people have already been infected. In...

Deadly Feasts: The "Prion" Controversy and the Public's Health

Deadly Feasts: The "Prion" Controversy and the Public's Health
by Richard Rhodes (Author)

In this brilliant and gripping medical detective story. Richard Rhodes follows virus hunters on three continents as they track the emergence of a deadly new brain disease that first kills cannibals in New Guinea, then cattle and young people in Britain and France -- and that has already been traced to food animals in the United States. In a new Afterword for the paperback, Rhodes reports the latest U.S. and worldwide developments of a burgeoning global threat.

Prion Biology and Diseases, Second Edition (Cold Spring Harbor Monograph Series)

Prion Biology and Diseases, Second Edition (Cold Spring Harbor Monograph Series)
by Stanley B. Prusiner (Author), Stanley B. Prusiner (Editor)

A new edition of the most authoritative book in its field, first published in 1999 and edited by the Nobel Prize–winning founder of the field. This edition is expanded and completely updated, and includes chapters on therapeutics, and diagnostic methods and approaches.

  Prion
by Landes Bioscience % Jesse



thirtytwo Women's Prion Snowboard Boot,White/Mint,8.5 M US

thirtytwo Women's Prion Snowboard Boot,White/Mint,8.5 M US
by thirtytwo



Prions: The New Biology of Proteins

Prions: The New Biology of Proteins
by Claudio Soto (Author)

The current interest in prion diseases has been fueled by the panic that originated from the appearance of a new variant of Creutzfeldt-Jakob disease and the evidence linking it to human exposure to the bovine spongiform encephalopathy (BSE) agent. Peer-reviewed to assure accuracy, this book describes the science, concepts, hypothesis, and mechanisms of prion disease transmission. It covers human and animal prion diseases, their incidence, prevalence, origin, and clinical and neuropathologic characteristics. The author provides scientific facts and a clear explanation of the relevance and implications of the findings for science in general.

thirtytwo Men's Prion Ft Snowboard Boot,Blue/White/Gum,10 M US

thirtytwo Men's Prion Ft Snowboard Boot,Blue/White/Gum,10 M US
by thirtytwo

The zonal lacing system on the ThirtyTwo Mens Prion Fast Track Snowboard Boot is so quick, easy, and precise, youll have a better fit and be ready to hit the chair faster than your buddy. This pisses him off since he turned in early last night and you partied til three (and are still functioning at 20 percent).

Product FeaturesMaterial: [Upper] synthetic; [Sole] rubberLacing System: Fast TrackFlex: 4 Out of 10 on ThirtyTwos scaleRemovable Liner: Yes, moldableRecommended Use: ShreddingManufacturer Warranty: 1 Year

  Time of Plagues
Prion (Performer)

Tracks include: Senseless Miseries, To the Abyss of Hell, Envy & Hate, The Plagues, Executed, Beyond the Period, Armenia, The Opposite, and Instrumental. Argentinian metal.

What Guys Want: Roberty Prion Adult Gay Video

What Guys Want: Roberty Prion Adult Gay Video
Starring: Jay Richards, Blake Andrews
Directed By: Robert Prion
Also With: Cody Marshall (Primary Contributor), Bryon Rogers (Primary Contributor), Vincent DeMarco (Primary Contributor), Michel Mattel (Primary Contributor), Gianni Pasquale (Primary Contributor), Dustin Jeffreys (Primary Contributor), Alex Turner (Primary Contributor), Scott Williams (Primary Contributor), Tyler Morgan (Primary Contributor), Rob Walker (Primary Contributor)

What Guys Want, like most of Robert Prion's skin flicks, is a low-budget romp-fest starring a cadre of young, slim "real"-looking guys. These are not the waxed, sculpted, groomed-within-an-inch-of-their-lives porn pups some viewers may be used to. The skinny boys in this video (with the exception of older brother type Jay Richards) resemble what one might find cruising the food court at a local mall. Most of the boys are pierced and/or tattooed. They feature nice parts and plenty of enthusiasm for their work.

Prions pour les éléphants (Instrumentale)

Prions pour les éléphants (Instrumentale)
Ruth zopo (Primary Contributor)



© 2009 BrightSurf.com